IBI305
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for IBI305, covering 2020-11-04 to 2024-10-31. Get the full timeline:
Most recent: Clinical Trial Update: CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer [Phase 2]